Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Merck & Co., Inc.MRK · Entity 2807 | Chief Comm. & Public Afrs Ofcr | November 10, 2025 | November 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Merck & Co., Inc.
Report date November 10, 2025 · Filed November 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-11-10 transaction · row 1
1 source rowRow 1 · 2025-11-10 · Sale · Disposed 7,085 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2025 Filed Nov 12, 2025 21:01 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 7,085 | $87.00 | $616,395.00 |
DisclosureSEC source: 0000310158-25-000061 · form4.xml · nonDerivative · entry 1 Downing Cristal N · CIK 0001879216 · Chief Comm. & Public Afrs Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| April 29, 2025 Filed May 1, 2025 22:00 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (Right to Buy) · Derivative | 13,971 | $0.00 Strike: $84.71 | $0.00 |
DisclosureSEC source: 0001127602-25-013034 · form4.xml · derivative · entry 3 Downing Cristal N · CIK 0001879216 · Chief Comm. & Public Afrs Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,971 Underlying: Common Stock · 13,971 shares Expires 2035-04-28 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028. Read SEC document |
| April 29, 2025 Filed May 1, 2025 22:00 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 3,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013034 · form4.xml · derivative · entry 2 Downing Cristal N · CIK 0001879216 · Chief Comm. & Public Afrs Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,069 Underlying: Common Stock · 3,069 shares Expires 2028-04-29 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 21:07 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 2,361 | $88.76 | $209,550.79 |
DisclosureSEC source: 0001127602-25-003552 · form4.xml · nonDerivative · entry 1 Downing Cristal N · CIK 0001879216 · Chief Comm. & Public Afrs Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,085 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.7533 to $88.7610, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 23:17 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 9,446 | $97.94 | $925,141.24 |
DisclosureSEC source: 0001127602-25-002344 · form4.xml · nonDerivative · entry 1 Downing Cristal N · CIK 0001879216 · Chief Comm. & Public Afrs Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,446 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/22. Performance shares were paid out at 169 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2024. Read SEC document |
| April 30, 2024 Filed May 2, 2024 20:20 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (Right to Buy) · Derivative | 15,234 | $0.00 Strike: $129.22 | $0.00 |
DisclosureSEC source: 0001127602-24-013970 · form4.xml · derivative · entry 1 Downing Cristal N · CIK 0001879216 · Chief Comm. & Public Afrs Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,234 Underlying: Common Stock · 15,234 shares Expires 2034-04-29 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027. Read SEC document |
| October 31, 2023 Filed Nov 1, 2023 19:49 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 11,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-026457 · form4.xml · derivative · entry 1 Downing Cristal N · CIK 0001879216 · Chief Comm. & Public Afrs Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,685 Underlying: Common Stock · 11,685 shares Expires 2026-10-31 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2 · derivative.exercise_date: These restricted stock units vest in full and are distributed as shares of Merck & Co., Inc. common stock on 10/31/2026. Read SEC document |
| May 02, 2023 Filed May 4, 2023 21:47 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (Right to Buy) · Derivative | 17,981 | $0.00 Strike: $117.89 | $0.00 |
DisclosureSEC source: 0001127602-23-014543 · form4.xml · derivative · entry 1 Downing Cristal N · CIK 0001879216 · Chief Comm. & Public Afrs Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,981 Underlying: Common Stock · 17,981 shares Expires 2033-05-01 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026. Read SEC document |
| May 03, 2022 Filed May 5, 2022 20:59 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (Right to Buy) · Derivative | 19,417 | $0.00 Strike: $87.10 | $0.00 |
DisclosureSEC source: 0001127602-22-013514 · form4.xml · derivative · entry 1 Downing Cristal N · CIK 0001879216 · Chief Comm. & Public Afrs Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,417 Underlying: Common Stock · 19,417 shares Expires 2032-05-02 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.